Advanced search
Publication Cover
Acta Oncologica Volume 33, 1994 - Issue 2
Journal homepage
300
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Targeted Chemotherapy for Unresectable Primary and Metastatic Liver Cancer

Toshimitsu Konno First Department of Surgery, Kumamoto University School of Medicine, Honjo 1–1-1, Kumamoto, Japan
,
Yousuke Kai First Department of Surgery, Kumamoto University School of Medicine, Honjo 1–1-1, Kumamoto, Japan
,
Ryoichi Yamashita First Department of Surgery, Kumamoto University School of Medicine, Honjo 1–1-1, Kumamoto, Japan
,
Akinori Nagamitsu First Department of Surgery, Kumamoto University School of Medicine, Honjo 1–1-1, Kumamoto, Japan
&
Masami Kimura First Department of Surgery, Kumamoto University School of Medicine, Honjo 1–1-1, Kumamoto, Japan
Pages 133-137 | Received 30 Jun 1993, Accepted 23 Aug 1993, Published online: 08 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Süha Cakmakli, Sadik Ersoz, Muammer Karaayvaz & Ali Riza Arat. (1996) A Prospective Evaluation of the Treatment of Primary or Metastatic Liver Carcinoma with Hepatic Arterial Infusion Chemotherapy. Acta Oncologica 35:4, pages 441-444.
Read now

Articles from other publishers (12)

Xiumei Zhu, Altansukh Tsend-Ayush, Zhongyue Yuan, Jing Wen, Jiaxin Cai, Shifu Luo, Jianxu Yao, Junxing Bian, Linfang Yin, Jianping Zhou & Jing Yao. (2017) Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy. International Journal of Pharmaceutics 529:1-2, pages 451-464.
Crossref
P. Moody, F. Burlina, S. R. Martin, R. E. Morgan, J. Offer, M. E. B. Smith, J. E. Molloy & S. Caddick. (2013) Evaluating the use of Apo-neocarzinostatin as a cell penetrating protein. Protein Engineering Design and Selection 26:4, pages 277-281.
Crossref
Akinori Nagamitsu, Khaled Greish & Hiroshi Maeda. (2009) Elevating Blood Pressure as a Strategy to Increase Tumor-targeted Delivery of Macromolecular Drug SMANCS: Cases of Advanced Solid Tumors. Japanese Journal of Clinical Oncology 39:11, pages 756-766.
Crossref
H. Maeda, K. Greish & J. Fang. 2006. Polymer Therapeutics II. Polymer Therapeutics II 103 121 .
David C. GammonSekhar RaoDucksoo KimPankaj BhargavaTimothy R. Bartlett. (2017) Superselective Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Experience with a New Emulsion. Hospital Pharmacy 39:9, pages 864-867.
Crossref
Khaled Greish, Jun Fang, Takao Inutsuka, Akinori Nagamitsu & Hiroshi Maeda. (2003) Macromolecular Therapeutics. Clinical Pharmacokinetics 42:13, pages 1089-1105.
Crossref
Hiroshi Maeda, Tomohiro Sawa & Toshimitsu Konno. (2001) Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. Journal of Controlled Release 74:1-3, pages 47-61.
Crossref
Shuichi Kishimoto, Kenji Miyazawa, Shoji Fukushima & Yoshikazu Takeuchi. (2005) In vitro Antitumor Activity, Intracellular Accumulation, and DNA Adduct Formation of cis ‐[((1 R , 2 R )‐1,2‐Cyclohexanediamine‐ N, N' )bis(myristato)] Platinum (II) Suspended in Lipiodol . Japanese Journal of Cancer Research 91:1, pages 99-104.
Crossref
Cynthia Gail Leichman, Joth R. Jacobson, Manuel Modiano, John R. Daniels, Mark M. Zalupski, James H. Doroshow, William S. Fletcher & John S. Macdonald. (1999) Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma. Cancer 86:5, pages 775-781.
Crossref
Francesco Izzo, Francesco Fiore, Carlo De Werra & Steven A. Curley. 1998. Liver Cancer. Liver Cancer 79 94 .
Masayuki Yokoyama & Teruo Okano. (1996) Targetable drug carriers: present status and a future perspective. Advanced Drug Delivery Reviews 21:2, pages 77-80.
Crossref
Anne Rudolphi, Stefan Vielhauer, Karl-Siegfried Boos, Dietrich Seidel, Ilse-Marie Bathge & Hermann Berger. (1995) Coupled-column liquid chromatographic analysis of epirubicin and metabolites in biological material and its application to optimization of liver cancer therapy. Journal of Pharmaceutical and Biomedical Analysis 13:4-5, pages 615-623.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.